Valuation: Krka, d. d.

Market Cap 7.85B 8.96B 7.29B 6.69B 12.61B 864B 12.8B 86.79B 33.97B 423B 33.62B 32.9B 1,461B P/E 2026 *
19x
P/E 2027 * 18x
Enterprise Value 7.17B 8.18B 6.65B 6.11B 11.52B 789B 11.69B 79.27B 31.03B 386B 30.71B 30.05B 1,334B EV / Sales 2026 *
3.31x
EV / Sales 2027 * 3.11x
Free-Float
74.74%
Yield 2026 *
3.5%
Yield 2027 * 3.86%
1 day+0.47%
1 week+0.94%
Current month+6.79%
1 month+2.29%
3 months+10.54%
6 months+21.59%
Current year+31.77%
1 week 258
Extreme 258
270
1 month 249.5
Extreme 249.5
270
Current year 202
Extreme 202
270
1 year 174
Extreme 174
270
3 years 100
Extreme 100
270
5 years 80
Extreme 80
270
10 years 48.01
Extreme 48.01
270
Manager TitleAgeSince
Chief Executive Officer 70 2004-12-31
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 59 2018-12-31
Director/Board Member 59 2004-12-31
Director/Board Member 59 2004-12-31
Change 5-day change 1-year change 3-year change Capi.($)
+0.47%+0.94%+34.42%+136.73% 8.95B
-0.96%+0.02%+14.81%+77.10% 48.88B
-0.99%-0.27%+66.69%+108.95% 35.72B
-1.21%-1.60%-3.99%+34.91% 12.02B
-1.47%-0.64%+16.11%+83.68% 11.84B
+0.33%-1.13%+50.36%-5.96% 6.91B
-0.34%-2.25%+14.42%+31.69% 6.78B
-1.88%-4.56%+0.69%+192.09% 6.57B
-2.47%-5.28%-33.67%+6.76% 5.81B
-3.26%+1.47%+24.55%+145.02% 4.64B
Average -1.18%-1.51%+18.44%+81.10% 14.81B
Weighted average by Cap. -1.03%-0.20%+26.51%+84.00%

Financials

2026 *2027 *
Net sales 2.17B 2.47B 2.01B 1.85B 3.48B 239B 3.53B 23.96B 9.38B 117B 9.28B 9.08B 403B 2.3B 2.62B 2.13B 1.96B 3.7B 253B 3.75B 25.42B 9.95B 124B 9.85B 9.64B 428B
Net income 420M 479M 390M 358M 675M 46.22B 685M 4.64B 1.82B 22.61B 1.8B 1.76B 78.12B 442M 504M 410M 377M 710M 48.65B 721M 4.89B 1.91B 23.81B 1.89B 1.85B 82.24B
Net Debt -680M -776M -631M -580M -1.09B -74.89B -1.11B -7.52B -2.94B -36.64B -2.91B -2.85B -127B -708M -808M -657M -604M -1.14B -77.94B -1.15B -7.83B -3.06B -38.14B -3.03B -2.97B -132B
Logo Krka, d. d.
Krka dd Novo Mesto is a Slovenia-based company engaged in the production of pharmaceutical preparations. The Company operates through four segments: Prescription Pharmaceuticals that includes medicines for the treatment of cardiovascular diseases, alimentary tract and metabolism and drugs for diseases of the central nervous system, among others; Non-prescription Products, providing vitamins and minerals, cough and cold products, analgesics, sore throat products, among others; Animal Health Products, which offers general anti-infectives and antiparasitics for animals; Health Resort and Tourist Services consisting of Spa resorts in Smarjeske Toplice, Dolenjske Toplice, Strunjan, Novo Mesto and Otocec. Krka dd Novo Mesto is a controlling company of the Krka Group that includes two subsidiaries in Slovenia, Terme Krka doo and Farma GRS doo, and over 20 subsidiaries abroad in such countries as Croatia, Germany, Sweden, Poland, Spain, United States, Ireland, among others.
Employees
13,204
Date Price Change Volume
26-07-19 267.50 -0.37% 5,940
26-07-22 €260.00 +0.39% 5,111
26-07-21 €259.00 -3.18% 12,756
26-07-20 €267.50 -0.37% 5,940
26-07-17 €268.50 +0.19% 2,096
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
260.00EUR
Average target price
242.65EUR
Spread / Average Target
-6.67%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KRKG Stock